Royal Philips Acquires Dameca

imageRoyal Philips Electronics yesterday announced that it has acquired Dameca, a global provider of anesthesia machines and operating room accessories. The acquisition marks a critical step in the execution of Philips’ plan to grow its portfolio with integrated, advanced anesthesia care solutions. Philips Healthcare CEO Steve Rusckowski deems the move a “proof point” of Philips’ growth strategy and ambitions to expand its anesthesia care offerings by combining its strengths in patient monitoring, therapeutic care, and clinical informatics. “Dameca’s anesthesia machines are a significant complement to our current operating room portfolio and will enable us to offer an integrated solution that will simplify clinician workflow, improve financial outcomes for our customers, and help improve patient care,” he notes. Along with Philips’ expertise and well-established position in patient monitoring, interventional imaging systems, and clinical informatics solutions, Dameca further broadens that company’s current portfolio and provides opportunity for innovation in such areas as anesthesia-related clinical decision support. Philips currently offers anesthesia machines in select countries through Dixtal Medical, which Philips acquired in 2008. Headquartered in Copenhagen, Denmark, Dameca was founded in 1947 and is a privately held company with approximately 70 employees. Its current product line includes anesthesia machines, wall panels, pendant systems, flow meters, suction units, and other accessories. The company uses direct sales channels in the Nordic countries, and serves over 60 countries globally through distributors. Financial terms of the acquisition were not disclosed.
Julie Ritzer Ross,

Contributor

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.